FC Bayern and URSAPHARM Arzneimittel GmbH, with its brand HYLO, are to continue their successful cooperation. The partnership, which has existed since 2017, has been extended by a further three years as a Gold Partner until 2029.
Rouven Kasper, board member for marketing and sales at FC Bayern: “In sport, as in life, the ability to see clearly is vital. The partnership between FC Bayern and HYLO has been marked by trust, continuity and shared goals for almost 10 years now. That makes us all the more pleased to not only be continuing this cooperation until 2029, but also to widen it to our basketball and women’s teams as well as the esports team. This reflects our joint ambition to continue raising public awareness of the socially important topic of eye health, and to expand our international activities in an even more targeted manner in the future.”
Christian Krensel, managing director of marketing and sales at URSAPHARM Arzneimittel GmbH: “Our partnership with FC Bayern has developed into a real success story over the last nine years. With the extension of our cooperation, we are strengthening our international visibility and we want to raise awareness among even more people on the topic of eye health, particularly in the strong growth markets of Asia and the Middle East. At the same time, the incorporation of the women’s and basketball teams as well as esports opens up new opportunities to reach different target groups, and to continue expanding our educational work regarding eye health.”
In addition to maintaining a strong focus on the European and Asian markets, Africa will take on an even greater role in the joint activities going forward. There will also be a particular emphasis on the United Arab Emirates.
Topics of this article